series-c-plus
Stage
1
Investors
About
Proteostasis Therapeutics is a biotech company developing small-molecule therapies that modulate the cellular proteostasis network to restore function of misfolded proteins, with applications including cystic fibrosis and other protein-misfolding diseases.
Explore Proteostasis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.